Our results show that CCL5 is released in vitro by PKC412‐resistant AML cell lines and ex vivo by AML blasts from FLT3‐ITD‐mutated and PKC412‐treated patients at relapse. The gene discussed is CCL5; the disease is acute myeloid leukemia.